Abstract 6670: Combined signals from tumor and immune cells predict outcomes of checkpoint inhibition in melanoma
Sign Up to like & getrecommendations! Published in 2020 at "Immunology"
DOI: 10.1158/1538-7445.am2020-6670
Abstract: Cancer immunotherapy with checkpoint blockade has improved survival and outcomes in melanoma, but still a majority of patients do not respond. Both high tumor mutation burden (TMB) and high T cell infiltration have been associated… read more here.
Keywords: melanoma; signals tumor; response; tmb high ... See more keywords